Table 3 Analysis of variance for the set of parameters studied in the three groups (postmenopausal, premenopausal, and control group) at the two evaluation time points (pre and post-test).
Post-menopausal | Pre-menopausal | Control | |||||||
|---|---|---|---|---|---|---|---|---|---|
t/z | p | Cohen’s d/r | t/z | p | Cohen’s d/r | t/z | p | Cohen’s d/r | |
TC (mg/dl) | -0.860t | 0.412 | 0.3389d | 0.516t | 0.613 | 0.075d | -1.197t | 0.262 | 0.154d |
LDL-C (mg/dl) | -0.127t | 0.902 | 0.048d | -0.054t | 0.958 | 0.195d | -1.680t | 0.127 | 0.257d |
HDL-C (mg/dl) | -1.379z | 0.168 | -0.436r | 0.772t | 0.451 | 0.128r | 0.594t | 0.567 | -0.581d |
TG (mg/dl) | -0.153z | 0.878 | -0.048r | -1.044z | 0.296 | -0.246r | -1.837z | 0.066 | -0.581r |
CRI-I (a.u.) | -0.370t | 0.720 | 0.131d | -0.414z | 0.679 | -0.098r | -1.351t | 0.210 | 0.183d |
CRI-II (a.u.) | 0.226t | 0.826 | 0.088d | -0.402z | 0.687 | -0.095r | -1.662t | 0.131 | 0.274d |
VLDL-C (mg/dl) | -0.153z | 0.878 | -0.048r | -1.044z | 0.296 | -0.246r | -1.837z | 0.066 | -0.581r |
Ga,b (mg/dl) | 1.192t | 0.264 | 0.444d | 3.266t | 0.005* | 0.791d | 1.075t | 0.310 | 0.301d |
SBPb (mmHg) | 3.736t | 0.005* | 1.409d | -3.311z | 0.001* | -0.78r | 0.83t | 0.936 | 0.012d |
DBPb (mmHg) | 3.914t | 0.004* | 1.490d | 4.213t | 0.005* | 1.025d | -0.922t | 0.381 | 0.133d |
HR (bpm) | -0.355t | 0.731 | 0.149d | -0.670t | 0.512 | 0.195d | -1.993t | 0.077 | 0.278d |
BMI (kg/m2) | 4.610t | 0.001* | 0.044d | 3.131t | 0.006* | 0.034d | -0.067t | 0.948 | 0.020d |
WC (cm) | 3.709t | 0.005* | 0.338d | 1.132t | 0.273 | 0.131d | 0.0t | 1.00 | 0 |
HP (cm) | 6.278t | 0.000* | 0.583d | 4.734t | 0.000* | 0.287d | -2.355t | 0.043* | 0.048d |
WC/HP (a.u.) | -1.360t | 0.207 | 0 | -0.833z | 0.405 | -0.196r | 0.721t | 0.489 | 0 |